Rethinking Goods and Services Tax (GST) and Academic Research in India

The Goods and Services Tax (GST), introduced in India on July 1, 2017, was envisioned as a landmark reform to unify indirect taxation, enhance transparency, and reinforce fiscal federalism. While celebrated for its efficiency, its uniform application to research‑related activities has generated significant concern across academia, medicine, and public health. Conference registration fees and continuing medical education (CME) costs have risen sharply, restricting opportunities for skill development among doctoral students, postdoctoral fellows, clinicians, and public health professionals. Escalating publication charges and subscription cancellations in state universities, teaching hospitals, and research institutes have curtailed access to international medical literature, limiting evidence‑based practice, policy formulation, and equitable knowledge dissemination. Procurement delays in national laboratories and medical research centers further impede innovation, slowing translation of discoveries into improved diagnostics, therapeutics, and preventive strategies. From the government’s perspective, uniform taxation prevents loopholes, curbs misuse of exemptions, and ensures consistency in revenue collection, with GST revenues earmarked for infrastructure, healthcare, and education. Yet, the imposition of an 18% GST on research and CME activities clashes with the lived experiences of researchers and healthcare professionals, who view it as undermining accessibility, equity, and timely adoption of global best practices. The downstream effects include weakened epidemic preparedness, delayed integration of innovations into healthcare delivery, and widening disparities in public health outcomes. Formal petitions from scientific academies, medical associations, industry bodies, and state assemblies underscore the urgency of reform. International comparisons reveal alternative fiscal models that balance efficiency with recognition of research and CME as public goods. This editorial argues for targeted reforms, such as concessional rates, exemptions for academic medical services, and sector‑specific subsidies, to align fiscal policy with India’s innovation and public health goals, ensuring taxation does not become a barrier to advancing healthcare equity and outcomes.